122 results
Search Results
2. Optimizing esketamine administration for postoperative depression: a comprehensive study on laparoscopic bariatric surgery patients
3. Content analysis of Reddit posts about coadministration of selective serotonin reuptake inhibitors and psilocybin mushrooms
4. Efficacy of ginsenoside Rg1 on rodent models of depression: A systematic review and meta-analysis
5. Mechanisms involved in the antidepressant-like action of orally administered 5-((4-methoxyphenyl)thio)benzo[c][1,2,5]thiadiazole (MTDZ) in male and female mice
6. Association between previous SARs-CoV-2 infection and new prescription of antidepressant drugs: a case-control study in Friuli Venezia Giulia region, Italy
7. The role of serotonin neurotransmission in rapid antidepressant actions
8. Neurotrophic factors and neuroplasticity pathways in the pathophysiology and treatment of depression
9. DSP-6745, a novel 5-hydroxytryptamine modulator with rapid antidepressant, anxiolytic, antipsychotic and procognitive effects
10. Alcohol and toxicological factors influencing fatal falls from height in the Greater Tokyo Area: a retrospective study
11. Pharmacological update of mirtazapine: a narrative literature review
12. The monoaminergic pathways are involved in the antidepressant-like effect of quercetin
13. Age of onset for increased dose-adjusted serum concentrations of antidepressants and association with sex and genotype: An observational study of 34,777 individuals
14. Neurobehavioral protective effects of Japanese sake yeast supplement against chronic stress-induced anxiety and depression-like symptoms in mice: Possible role of central adenosine receptors
15. Venlafaxine’s therapeutic reference range in the treatment of depression revised: a systematic review and meta-analysis
16. A repeated measures cognitive affective bias test in rats: comparison with forced swim test
17. mGlu2/3 receptor antagonists for depression: overview of underlying mechanisms and clinical development
18. Preclinical and clinical pharmacology of brexanolone (allopregnanolone) for postpartum depression: a landmark journey from concept to clinic in neurosteroid replacement therapy
19. The effect of ketamine and D-cycloserine on the high frequency resting EEG spectrum in humans
20. Effects of psychotropic drugs on inflammation: consequence or mediator of therapeutic effects in psychiatric treatment?
21. Ropanicant (SUVN-911), an α4β2 nicotinic acetylcholine receptor antagonist intended for the treatment of depressive disorders: pharmacological, behavioral, and neurochemical characterization
22. Healthcare use for major depressive disorders among middle-aged and older adults in the community
23. Investigation of Cochlospermum religiosum leaves for antidepressant and anxiolytic activities and its synergistic effect with imipramine and fluoxetine
24. Trajectories of antidepressant use and characteristics associated with trajectory groups among young refugees and their Swedish-born peers with diagnosed common mental disorders—findings from the REMAIN study
25. Antidepressant activity of pharmacological and genetic deactivation of the small-conductance calcium-activated potassium channel subtype-3
26. No antidepressant-like acute effects of bright light on emotional information processing in healthy volunteers
27. Antidepressant-like effect of Ganoderma lucidum spore polysaccharide-peptide mediated by upregulation of prefrontal cortex brain-derived neurotrophic factor
28. Loganin ameliorates depression-like behaviors of mice via modulation of serotoninergic system
29. Sudden cessation of fluoxetine before alcohol drinking reinstatement alters microglial morphology and TLR4/inflammatory neuroadaptation in the rat brain
30. The effects of antidepressants fluoxetine, sertraline, and amitriptyline on the development of antibiotic resistance in Acinetobacter baumannii
31. Is ionizing radiation effective in removing pharmaceuticals from wastewater?
32. Melancholic features (DSM-IV) predict but do not moderate response to antidepressants in major depression: an individual participant data meta-analysis of 1219 patients
33. Splenic NKG2D confers resilience versus susceptibility in mice after chronic social defeat stress: beneficial effects of (R)-ketamine
34. Similar clinical improvement of depression using 0.5-ms and 1-ms pulse widths in bilateral electroconvulsive therapy
35. Initiation of antidepressant use among refugee and Swedish-born youth after diagnosis of a common mental disorder: findings from the REMAIN study
36. Characteristics of completed suicides after Greek financial crisis onset: A comparative time-series analysis study
37. The kappa opioid receptor antagonist aticaprant reverses behavioral effects from unpredictable chronic mild stress in male mice
38. The involvement of GABAergic system in the antidepressant-like effect of agmatine
39. New antidepressant utilization pre- and post-bereavement: a population-based study of partners and adult children
40. Role of serotonin and norepinephrine transporters in antidepressant-induced arterial hypertension: a pharmacoepidemiological-pharmacodynamic study
41. Comparison of acute treatment with delayed-onset versus rapid-acting antidepressants on effort-related choice behaviour
42. Effects of repeated treatment with monoamine-transporter-inhibitor antidepressants on pain-related depression of intracranial self-stimulation in rats
43. Decreased sensitivity in adolescent versus adult rats to the antidepressant-like effects of cannabidiol
44. In vitro effects of antidepressants and mood-stabilizing drugs on cell energy metabolism
45. Efficacy and safety of non-benzodiazepine and non-Z-drug hypnotic medication for insomnia in older people: a systematic literature review
46. Pharmacotherapy of psychiatric inpatients with adjustment disorder: current status and changes between 2000 and 2016
47. Classical conditioning of antidepressant placebo effects in mice
48. S-Adenosylmethionine (SAMe) monotherapy for depression: an 8-week double-blind, randomised, controlled trial
49. Hypovitaminosis D is associated with negative symptoms, suicide risk, agoraphobia, impaired functional remission, and antidepressant consumption in schizophrenia
50. Concurrent use of benzodiazepines, antidepressants, and opioid analgesics with zolpidem and risk for suicide: a case–control and case–crossover study
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.